EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Microneedles for the treatment of migraine and orofacial pain: A narrative review

Baicheng Cao iD, Qiuyi Chen, Yuhan Liu iD, Ruozhou Wu, Bin Li, Qing Cai, Lu Liu iD

Headache: The Journal of Head and Face Pain · 2026-05 · 66 (5) · 1148-1161

DOI: 10.1111/head.70074 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 13.03.2026. Verfasst von Baicheng Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture and Moxibustion, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing Hospital of Traditional Chinese Medicine, C…. Hauptthemen laut MEDLINE: Facial Pain, Microneedle Drug Delivery, Migraine Disorders, Analgesics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Hospital Management Center "peak" talent-training plan team, Beijing Chronic Disease Prevention and Health Education Research Association, Zhongguancun Talent Association Medical-Engineering Field Future Talent Training…, Beijing Municipal Traditional Chinese Medicine Research Institute Municipal Finance Independent Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Migraine is a common neurological disorder and a primary headache condition. Despite its central origin, migraine pain may be referred to the orofacial region via trigeminal pathways, resulting in phenotypic overlap with other orofacial pain (OFP) conditions. OFP represents a highly prevalent and heterogeneous group of pain disorders that substantially impair quality of life. Microneedle (MN) technology enables minimally invasive, localized, or transdermal drug delivery and has emerged as a promising mechanism‐guided strategy for the management of migraine and other OFP conditions.

Objective

This review aims to systematically summarize the current evidence on MN‐based technologies for the treatment of migraine and other OFP conditions and discuss the therapeutic implications, limitations, and future directions of MN technologies.

Methods

This study is a narrative review. PubMed/MEDLINE, Embase, Web of Science, and Google Scholar were systematically searched from inception to November 18, 2025. English‐language studies evaluating MN‐based technologies for migraine and other OFP conditions, including temporomandibular disorders (TMD) and oral mucosal ulcers, in animal models or human participants were included.

Results

Eleven studies were included, covering migraine ( n = 4), TMD ( n = 2), and oral mucosal ulcers ( n = 5). Across included studies, evidence for MN‐based interventions was most advanced in migraine. Preclinical studies demonstrated that transdermal or intranasal MN systems enabled rapid and reliable drug absorption, with bioavailability comparable to subcutaneous injection. Clinical studies of MN‐mediated triptan delivery reported high rates of 2 h pain relief and freedom from the most bothersome migraine‐associated symptoms, with generally mild and transient local skin reactions. Beyond migraine, MNs were explored for TMD and oral mucosal ulcers, where they enabled localized and sustained analgesic and anti‐inflammatory effects and promoted tissue healing, although evidence in these conditions remains limited and largely preclinical.

Conclusions

MN‐based drug delivery represents a promising, minimally invasive strategy for migraine and other OFP management, with the strongest and most clinically relevant evidence currently available for acute migraine treatment. By enabling rapid and reliable drug absorption while bypassing gastrointestinal limitations, MNs may enhance the effectiveness of migraine‐specific therapies. Emerging preclinical evidence further suggests potential applicability of MN platforms in other OFP conditions, including TMD and oral mucosal ulcers, through localized and sustained analgesic and anti‐inflammatory delivery. Future research should prioritize migraine‐focused optimization of MN materials and designs, alongside disease‐specific expansion and standardized pain‐related outcome reporting, to facilitate broader clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Facial PainMicroneedle Drug DeliveryMigraine DisordersAnalgesicsDrug Delivery SystemsHumansAnimalsAdministration, Cutaneous

Stichwörter der Autor:innen

drug deliverymicroneedlesmigraineoral mucosal ulcersorofacial paintemporomandibular disorders

Substanzen

Analgesics

Autor:innen und Institutionen

  • Department of Acupuncture and Moxibustion, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China.
  • State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, People's Republic of China.

ORCID-Profile: Baicheng Cao, Yuhan Liu, Lu Liu

Förderung

  • Beijing Hospital Management Center "peak" talent-training plan team
  • Beijing Chronic Disease Prevention and Health Education Research Association, Zhongguancun Talent Association Medical-Engineering Field Future Talent Training…
  • Beijing Municipal Traditional Chinese Medicine Research Institute Municipal Finance Independent Research Project
  • Outstanding Young Talents Program of Capital Medial University
  • China National Natural Science Foundation
  • 2025 High-Level Innovation Program-Youth Seedlings Project
  • Capital's Funds for Health Improvement and Research

Zitieren

APA

Cao, B., Chen, Q., Liu, Y., Wu, R., Li, B., Cai, Q., & Liu, L. (2026). Microneedles for the treatment of migraine and orofacial pain: A narrative review. Headache: The Journal of Head and Face Pain, 66(5), 1148-1161. https://doi.org/10.1111/head.70074

Vancouver

Cao B, Chen Q, Liu Y, Wu R, Li B, Cai Q, et al. Microneedles for the treatment of migraine and orofacial pain: A narrative review. Headache: The Journal of Head and Face Pain. 2026;66(5):1148-1161. doi:10.1111/head.70074

BibTeX
@article{Cao2026,
  author = {Cao, Baicheng and Chen, Qiuyi and Liu, Yuhan and Wu, Ruozhou and Li, Bin and Cai, Qing and Liu, Lu},
  title = {Microneedles for the treatment of migraine and orofacial pain: A narrative review},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  volume = {66},
  number = {5},
  pages = {1148--1161},
  doi = {10.1111/head.70074}
}
Kostenlos starten →